Massamiri T, Tobias P S, Curtiss L K
Department of Immunology, Scripps Research Institute, La Jolla, CA 92037, USA.
J Lipid Res. 1997 Mar;38(3):516-25.
The interaction of lipopolysaccharide binding protein (LBP) with apolipoprotein (apo)A-I on high density lipoproteins (HDL) was studied in solid phase ligand binding assays with a biotinylated LBP-specific antibody. The association was dependent on LBP concentration and enhanced in the presence of lipopolysaccharide (LPS). Maximal enhancement was measured at an LPS/LBP molar ratio of 6. To identify regions on apoA-I that participate directly or indirectly in the interaction between LBP and HDL, we attempted to inhibit LBP association with a panel of mapped apoA-I-specific monoclonal antibodies. Whereas some antibodies were effective inhibitors, others were not, even though they bound apoA-I. Furthermore, selected apoA-I synthetic peptides inhibited the antibody-mediated interference of the HDL/LBP interaction. Although no specific mechanism can be defined for the basis of the inhibitory effects of the antibodies on the association of LBP with HDL, we identified a role for three unique regions on apoA-I between residues 1-31, 95-164, and 178-200. These results suggested that apoA-I is a key component in the association of LBP with HDL and may play an important role in the biologic activity of LPS/LBP complexes.
在使用生物素化的LBP特异性抗体进行的固相配体结合试验中,研究了脂多糖结合蛋白(LBP)与高密度脂蛋白(HDL)上载脂蛋白(apo)A-I的相互作用。这种结合依赖于LBP浓度,并且在脂多糖(LPS)存在时增强。在LPS/LBP摩尔比为6时测得最大增强效果。为了确定apoA-I上直接或间接参与LBP与HDL相互作用的区域,我们尝试用一组已定位的apoA-I特异性单克隆抗体抑制LBP结合。尽管有些抗体是有效的抑制剂,但其他抗体即使能结合apoA-I也无效。此外,选定的apoA-I合成肽抑制了抗体介导的HDL/LBP相互作用的干扰。虽然无法为抗体对LBP与HDL结合的抑制作用确定具体机制,但我们确定了apoA-I上1-31、�5-164和178-200残基之间三个独特区域的作用。这些结果表明,apoA-I是LBP与HDL结合的关键成分,可能在LPS/LBP复合物的生物学活性中起重要作用。